Drug Discovery World

APRIL 24, 2024

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.

Pharma R&D 130

Pharma R&D Government Regulations Drug Development 130

DrugBaron

JANUARY 31, 2024

Both the cost and the time required for each new drug approval have increased exponentially for decades (aptly tagged ‘Eroom’s Law’, being the inverse of price drops and speed gains in the semiconductor industry). There is, of course, no evidence of whether the claims made for AI in discovery and development are hype or reality.

Pharma R&D 165

Pharma R&D Science Small Molecule Pharma Companies 165

Drug Discovery World

AUGUST 7, 2024

Ashu Singhal and Sajith Wickramasekara , co-founders of Benchling, explore how AI’s true promise for the pharmaceutical industry can only be realised if the entire pharmaceutical R&D lifecycle is supported. Drug discovery has quickly become a trendy place to apply AI.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173